A cancer center director’s try-it-all strategy to build trust in clinical trials; success for Alnylam heart disease therapy

Black residents had reason to distrust the hospital at Virginia Commonwealth University. Robert Winn is building trust any way he can. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      The trust-builder: a cancer center director's try-it-all strategy for breaking the barriers between research and Black patients By Angus Chen Carlos Bernate for STAT Black residents had reason to distrust the hospital at Virginia Commonwealth University. Robert Winn is building trust any way he can. Read More Red Cross beginning to screen blood donors for monkeypox By Megan Molteni Jon Cherry/Getty Images As monkeypox continues its relentless spread, organizations in the U.S. are taking steps to safeguard the nation's blood supply. Read More STAT+: Alnylam therapy for increasingly common heart disease succeeds in closely watched trial By Damian Garde Ruby Wallau for STAT The results clear the path to approval and affirm the promise of a drug analysts expect to reap blockbuster sales. Read More Sponsor content by Salesforce STAT E-Book: How technology shapes patient experiences Our latest e-book underscores the vast range of technologies that are shaping how patients find and receive health care, from smartphone apps to deliver therapy and bedside bots to channel medication requests to new tools to collect real-world data and wearable watches to detect heart health. These stories illustrate the exciting advances being made on these technologies, and highlight the challenges to their broader adoption. Download now. STAT+: Civica Rx begins selling its first outpatient generic drug as it tries to overhaul the pharmaceutical supply chain By Ed Silverman Adobe "There are warped incentives in our drug distribution channel," said Antonio Ciaccia, who heads 46brooklyn Research. Read More Opinion: Inching closer to an essential global pandemic treaty By Lawrence O. Gostin and Kevin A. Klock and Sam F. Halabi Adobe Creating a global pandemic treaty will help the world prevent and respond to future infectious disease threats. Read More Opinion: Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation By Dana P. Goldman and Edith A. Perez and Carlos del Rio Adobe Incentives can nudge biopharma companies and contract research organizations to increase participant diversity in clinical trials. Read More Wednesday, August 3, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser